Senti Biosciences Holdings Working Capital Growth & History (SNTI)

Senti Biosciences Holdings's working capital was $9.3M for fiscal 2025.

View full Senti Biosciences Holdings company overview

Senti Biosciences Holdings annual working capital history

Senti Biosciences Holdings annual working capital

Fiscal yearPeriod endedWorking capitalChangeGrowth
20252025-12-31$9.3M−$36.5M−79.70%
20242024-12-31$45.8M−$12.7M−21.72%
20232023-12-31$58.5M−$26.0M−30.76%
20222022-12-31$84.5M$38.9M+85.16%
20212021-12-31$45.6M

Senti Biosciences Holdings working capital trends

Between the periods ended 2021-12-31 and 2025-12-31, Senti Biosciences Holdings's working capital decreased from $45.6M to $9.3M, a change of −$36.4M. The latest reported quarter, Q2 2026, shows −$2.8M.

About the metric

What working capital means

Working capital is the difference between current assets and current liabilities. It provides a snapshot of short-term operating liquidity, although negative working capital can be normal for some business models and the measure is often not meaningful for banks.

Calculation and source

How working capital is calculated

TickerStat calculates working capital as reported current assets minus reported current liabilities at the same balance-sheet date. Missing current classifications are not assumed to be zero. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Senti Biosciences Holdings source filings ↗

Community posts

It’s quiet here.

No posts about SNTI yet. Start the conversation.

Write the first post